(Total Views: 384)
Posted On: 02/07/2020 7:09:30 AM
Post# of 153937
Cancer Patient Rundown
Super excited with the continuous great news on cancer. That being said, I do sometimes find it difficult to stitch together the details on the patients being treated as they seem to be referred to using different statistics and/or patient #'s depending on the interview/PR/etc. I took some time and cross referenced the PRs with CCs and investor videos and have started to create a log. I wanted to offer it up in case it helps anyone else. Note: the information isn't always exact in nature and is often times relative (i.e. "a few weeks ago"
...I have put the word-for-word general phrase used in quotations and then extrapolated to more specific dates based on context. Anyhow, hope this helps. Feel free to correct or add to if you see fit.
6 Patients Enrolled
Patient #1
Diagnosis: mTNBC
Injected: 9/27/2019
"2 Weeks Later" (Oct)
-CTC 5->0
"Next Three Months" (Nov/Dec/Jan)
-EMT and CTC remain 0
Date Near 1/22
-only one CAML in one of two tubes
Patient #2 (MIL)
Diagnosis: HER2+ MBC Metastasized to Lung, Liver and Brain
Dosage: 2 Months of 700mg doses as monotherapy
Injected: 11/25/2019
"For a Year and a Half" (December 2018/January 2019)
-treated with pertuzumab and trastuzumab
June 27, 2019
-had metastasis to brain
-11 days of radiation
"3 Months Later" (Sept/Oct)
-patient had reacted positive to radiation
-told she will not live much longer because these spots will be increasing
-next 2 months she did not get leronlimab
November 25, 2019
-started 700mg weekly doses of leronlimab
January 17, 2020
-main tumor in brain reduced 56%
-everything stable
-radiologist going to give radiation a second time cancelled
-MRI shows 18 lesions down to 3
Patient #3
Diagnosis: ?
Injected: 1/7/2020
"2 Weeks Later" (January 2020)
-CTC and EMT 9 -> 2
Patient #4
Diagnosis: mTNBC
Injected: 1/2/2020
January 31, 2020
-CAML 45 -> 30
Patient #5
Patient #6
Super excited with the continuous great news on cancer. That being said, I do sometimes find it difficult to stitch together the details on the patients being treated as they seem to be referred to using different statistics and/or patient #'s depending on the interview/PR/etc. I took some time and cross referenced the PRs with CCs and investor videos and have started to create a log. I wanted to offer it up in case it helps anyone else. Note: the information isn't always exact in nature and is often times relative (i.e. "a few weeks ago"
...I have put the word-for-word general phrase used in quotations and then extrapolated to more specific dates based on context. Anyhow, hope this helps. Feel free to correct or add to if you see fit. 6 Patients Enrolled
Patient #1
Diagnosis: mTNBC
Injected: 9/27/2019
"2 Weeks Later" (Oct)
-CTC 5->0
"Next Three Months" (Nov/Dec/Jan)
-EMT and CTC remain 0
Date Near 1/22
-only one CAML in one of two tubes
Patient #2 (MIL)
Diagnosis: HER2+ MBC Metastasized to Lung, Liver and Brain
Dosage: 2 Months of 700mg doses as monotherapy
Injected: 11/25/2019
"For a Year and a Half" (December 2018/January 2019)
-treated with pertuzumab and trastuzumab
June 27, 2019
-had metastasis to brain
-11 days of radiation
"3 Months Later" (Sept/Oct)
-patient had reacted positive to radiation
-told she will not live much longer because these spots will be increasing
-next 2 months she did not get leronlimab
November 25, 2019
-started 700mg weekly doses of leronlimab
January 17, 2020
-main tumor in brain reduced 56%
-everything stable
-radiologist going to give radiation a second time cancelled
-MRI shows 18 lesions down to 3
Patient #3
Diagnosis: ?
Injected: 1/7/2020
"2 Weeks Later" (January 2020)
-CTC and EMT 9 -> 2
Patient #4
Diagnosis: mTNBC
Injected: 1/2/2020
January 31, 2020
-CAML 45 -> 30
Patient #5
Patient #6
(3)
(0)
